Fill in the form below and our experts will get back to you within 1 business day.
Accelerate your recombinant protein production with our baculovirus expression vector system. From small-scale pilot studies to large-scale industrial production, we deliver high quality proteins using Sf9 and High Five insect cell lines with industry-leading turnaround times.
Trusted by leading research and pharmaceutical institutions
Recombinant proteins up to 200 kDa
Virus-like particle production
Complex protein production
Our baculovirus expression vector system (BEVS) platform delivers high quality recombinant proteins with proper post-translational modifications for research and therapeutic applications.
Our optimized baculovirus expression vector system uses Autographa californica multiple nucleopolyhedrovirus (AcMNPV) for high-level recombinant protein expression in insect cells. The system supports proper protein folding, glycosylation, and post-translational modifications.
We offer proprietary insect cell lines engineered for enhanced protein production. These cell lines have been optimized to improve yield and product quality while maintaining proper post-translational modifications.
From 1 mg pilot scale to multi-gram industrial production with consistent quality.
Comprehensive QC including SDS-PAGE, western blot, mass spectrometry, and endotoxin testing.
Purity analysis, biological activity assays, and detailed characterization reports.
Get a customized quote for your insect cell expression needs.
State-of-the-art baculovirus expression systems optimized for maximum protein yield and quality.
Proprietary baculovirus transfer vectors with strong polyhedrin or p10 promoters for high-level expression. Multi-gene co-expression vectors available for complex proteins and protein complexes.
Two premier insect cell lines: Sf9 for general expression and baculovirus production, and High Five for high-yield secretory protein production. Both cells support complex post-translational modifications.
Systematic optimization of infection parameters including MOI, harvest time, temperature, and media composition to maximize protein yield for each specific target.
Comprehensive specifications to meet your research and industrial requirements.
| Parameter | Standard Service | Premium Service | Large Scale |
|---|---|---|---|
| Cell Line | Sf9 or High Five | Sf9 or High Five | High Five |
| Expression Scale | 100 mL - 1 L | 1 - 10 L | 10 - 100+ L |
| Turnaround Time | 3-4 weeks | 4-6 weeks | 6-10 weeks |
| Target Protein Size | Up to 200 kDa | Up to 200 kDa | Up to 200 kDa |
| Purification | Affinity + QC | Affinity + SEC + QC | Custom purification |
| Deliverables | Purified protein + COA | Purified protein + full QC data | Bulk protein + documentation |
Our proven 5-step workflow ensures quality and efficiency at every stage.
Subcloning into baculovirus vector
Baculovirus production in Sf9 cells
Protein production in insect cells
Affinity and polishing steps
Quality testing and shipment
Our insect cell expression platform supports research and development in multiple fields.
The baculovirus expression system is ideal for vaccine antigen production, including virus-like particles (VLPs) and recombinant subunit vaccines. Our platform supports rapid vaccine development with scalable production.
Insect cell expression produces complex mammalian proteins with proper folding and post-translational modifications. The BEVS platform supports development of therapeutic biologics including antibodies, enzymes, and growth factors.
High quality recombinant proteins for structural biology, biochemical assays, and functional studies. Our expression platform supports protein production for X-ray crystallography, cryo-EM, and other research applications.
Trusted by researchers worldwide for quality and reliability.
"The VLP production service exceeded our expectations. The quality of the virus-like particles was excellent and the immunogenicity studies showed great results. Highly recommended for vaccine development projects."
"We needed a challenging membrane protein for structural studies. The High Five cells produced excellent results with proper folding. The team provided valuable optimization recommendations throughout the project."
"Scalable production from milligram to multigram scale with consistent quality. The baculovirus system has become our go-to platform for therapeutic protein development. Professional service and excellent communication."
Our platform is backed by peer-reviewed research.
Manon M. J. Cox. Vaccines. 2021.
Review of latest technological innovations in insect cell expression systems covering vaccine antigen industrial production.
Grose C, et al. Protein Expression and Purification. 2021.
Review of alternative promoter strategies for optimal recombinant protein expression in baculovirus-infected insect cells.
Duygu Sari-Ak, et al. Viruses. 2023.
Systematic review of CRISPR-Cas9 technology applications in baculovirus vector systems including BEVS and CRISPR-Cas integration.
Minqing Hong, et al. Frontiers in Bioengineering and Biotechnology. 2022.
Review of genetic engineering approaches to improve protein production in baculovirus-insect cell systems.
Xiaoyue Zhang, et al. Frontiers in Microbiology. 2023.
Improving BEVS protein production by removing nonessential genomic fragments from AcMNPV.
Find answers to common questions about our service.
Get a customized quote for your Protein expression in insect cells project. Our experts will respond within 24 hours.
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.